Menactra Injection, Solution
Product Images NDC 49281-589

2 FDA label images from Sanofi Vaccines Us Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Menactra (NDC 49281-589). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Vial Label)

Principal Display Panel (0.5 mL Vial Label)
Label for Menactra Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Groups A, C, Y, and W-135. It is a single-dose 0.5 mL intramuscular injection. The label includes the NDC 49281-589-58 and indicates the manufacturer as Sanofi Pasteur Inc.*
FDA Label Image

Principal Display Panel (5 Vial Package)

Principal Display Panel (5 Vial Package)
Label for Menactra Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, intramuscular injection. The label indicates the package contains 5 single-dose vials. It shows the NDC 49281-589-05 and manufacturer as Sanofi Pasteur. Storage instructions specify 2° to 8°C (35° to 46°F) and no preservative is included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.